Solentim: Aiming for growthMark Truesdale has been appointed to the position of CEO at Life Sciences company Solentim. more ➔
Nordic Nanovector: Provisional headCTO Lars Nieba has taken over as interim CEO at Nordic Nanovectors after Eduardo Bravo’s sudden departure. more ➔
Nouscom: Made officialShe was already serving as interim CEO since Nouscom founder Alfredo Nicosia retired in May 2019. Now, Marina Udiers appointment at the Basel-based immuno-oncology company has been made permanent. more ➔
TrakCel: New at the helmCo-founder Fiona Withey is the new Chief Executive Officer of TrakCel, a software developer of orchestration systems for advanced therapies. Co-founder Ravi Nalliah was appointed to the role of Chief … more ➔
Applied Photophysics: Permanent headApplied Photophysics Limited, active in biophysical characterization of biomolecules, has appointed Tim Flanagan as Chief Executive Officer and member of the Board of Directors. more ➔
Centrient Pharmaceuticals: New CEOEx-Sandoz Head of Global Franchises Rex Clements is taking over as CEO of Centrient Pharmaceuticals. Erstwhile Centrient CEO Karl Rotthier has decided to step down, the company said. more ➔
Sofinnova: Industrial biotech promotionEuropean venture capital firm Sofinnova Partners announced the promotion of Michael Krel to Partner of the Industrial Biotechnology team. Krel previously served as Principal on the team, where he focused … more ➔
Ipsen: New VP and CMO incoming Ipsen has named steven Hildemann as Executive Vice President, Chief Medical Officer, Head of Global Medical Affairs and Pharmacovigilance, effective March 2020. more ➔
Wellington Partners: Sideways moveKarl Naegler, who has been a partner at the investment company Gimv since 2011, has joined the competition. He is now Managing Partner at leading European venture capital firm Wellington Partners. more ➔
Zelluna: Scientist turns CEONorwegian biopharma company Zelluna Immunotherapy appointed erstwhile CSO Namir Hassan as Chief Executive Officer. more ➔
